Anna Bissola

Anna completed her BAS at the University of Guelph in Biochemistry with a minor in History in 2019. She then received her MSc in Biochemistry and Biomedical Sciences from McMaster University where she designed inhibitors to help improve the diagnosis and treatment of antibody-mediated thrombotic disorders. Anna joined the Penn lab in 2023 as a research technician and is currently focused on developing assays to target MYC oncoprotein activity in cancer.